Clinical trial
A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, &…
NCT00437229 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00437229 |
|---|---|
| Title | A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults |
| Official title | An Open-Label, Phase I Study to Assess the Pharmacokinetic Interaction Between Repeat Doses of Oral Casopitant and Intravenous and Oral Doses of Dexamethasone and Intravenous and Oral Doses of Ondansetron When Administered in Healthy Adult Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Nausea and Vomiting, Chemotherapy-Induced |
| Intervention type | Drug |
| Interventions | Casopitant (GW679769) Oral Tablets, dexamethasone, ondansetron |
| Enrollment | 37 |
| Start date | Feb 19, 2007 |
| Primary completion | May 15, 2007 |
| Completion | May 15, 2007 |
| First posted | Feb 19, 2007 |
| Last update posted | Nov 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: